Previous 10 | Next 10 |
BioDelivery Sciences ([[BDSI]] +7.8%) Q3 results:Revenues: $39.4M (+30%) in-line with consensus; product sales: $38.79M (+30.9%).Net income: $9.4M vs $0.35M a year ago; income/share: $0.09 vs $0 a year ago; non-GAAP net income: $12.7M vs $3.52M a year ago.Cash flow ops: $14M (+339.3%).EBITDA ...
BioDelivery Sciences (BDSI): Q3 GAAP EPS of $0.09 beats by $0.04.Revenue of $39.4M (+30.0% Y/Y) in-line.Press Release For further details see: BioDelivery Sciences EPS beats by $0.04, revenue in-line
Total Company Net Revenue Increased 30% versus Prior Year Reaching a Record $39.4 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly gr...
Top Biotech Penny Stocks To Watch Right Now Are top biotech penny stocks on your watch list right now? If not, you may want to take a look at the industry. Over the last two days, one of the small cap stocks , Aptevo Therapeutics Inc. ( APVO Stock Report ) began captivating ...
BioDelivery Sciences (BDSI) has authorized repurchase of its common shares up to $25M of the Company’s common stock. “This share repurchase program reflects our confidence in the long-term outlook for the Company, including our ability to generate strong cash flow,” said ...
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that its Board of Directors has authori...
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that its Board of Directors has appoint...
RALEIGH, N.C., Oct. 23, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its third quarter 2020 f...
The following slide deck was published by BioDelivery Sciences International, Inc. in conjunction with this Read more ...
RALEIGH, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced the presentation of five scientific posters highlighting d...
News, Short Squeeze, Breakout and More Instantly...
BioDelivery Sciences International Inc. Company Name:
BDSI Stock Symbol:
NASDAQ Market:
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...